iopromide has been researched along with Atrophy in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, JH | 1 |
| Lee, JM | 1 |
| Kim, SH | 2 |
| Kim, SJ | 1 |
| Lee, JY | 1 |
| Han, JK | 1 |
| Choi, BI | 1 |
1 other study available for iopromide and Atrophy
| Article | Year |
|---|---|
Small (
Topics: Adolescent; Adult; Aged; Analysis of Variance; Atrophy; Calcinosis; Carcinoma, Papillary; Chi-Square | 2010 |